The effects of a number of vaccination strategies on the spread of an SIR type disease are numerically investigated for several common network topologies including random, scale-free, small world, and meta-random networks. These strategies, namely, prioritized, random, follow links and contact tracing, are compared across networks using extensive simulations with disease parameters relevant for viruses such as pandemic influenza H1N1/09. Two scenarios for a network SIR model are considered. First, a model with a given transmission rate is studied. Second, a model with a given initial growth rate is considered, because the initial growth rate is commonly used to impute the transmission rate from incidence curves and to predict the course of an epidemic. Since a vaccine may not be readily available for a new virus, the case of a delay in the start of vaccination is also considered in addition to the case of no delay. It is found that network topology can have a larger impact on the spread of the disease than the choice of vaccination strategy. Simulations also show that the network structure has a large effect on both the course of an epidemic and the determination of the transmission rate from the initial growth rate. The effect of delay in the vaccination start time varies tremendously with network topology. Results show that, without the knowledge of network topology, predictions on the peak and the final size of an epidemic cannot be made solely based on the initial exponential growth rate or transmission rate. This demonstrates the importance of understanding the topology of realistic contact networks when evaluating vaccination strategies.
The effects of a number of vaccination strategies on the spread of an SIR type disease are numerically investigated for several common network topologies including random, scale-free, small world, and meta-random networks. These strategies, namely, prioritized, random, follow links and contact tracing, are compared across networks using extensive simulations with disease parameters relevant for viruses such as pandemic influenza H1N1/09. Two scenarios for a network SIR model are considered. First, a model with a given transmission rate is studied. Second, a model with a given initial growth rate is considered, because the initial growth rate is commonly used to impute the transmission rate from incidence curves and to predict the course of an epidemic. Since a vaccine may not be readily available for a new virus, the case of a delay in the start of vaccination is also considered in addition to the case of no delay. It is found that network topology can have a larger impact on the spread of the disease than the choice of vaccination strategy. Simulations also show that the network structure has a large effect on both the course of an epidemic and the determination of the transmission rate from the initial growth rate. The effect of delay in the vaccination start time varies tremendously with network topology. Results show that, without the knowledge of network topology, predictions on the peak and the final size of an epidemic cannot be made solely based on the initial exponential growth rate or transmission rate. This demonstrates the importance of understanding the topology of realistic contact networks when evaluating vaccination strategies.
For many viral diseases, vaccination forms the cornerstone in managing their spread and the question naturally arises as to which vaccination strategy is, given practical constraints, the most effective in stopping the disease spread. For evaluating the effectiveness of a vaccination strategy, it is necessary to have as precise a model as possible for the disease dynamics.The widely studied key reference models for infectious disease epidemics are the homogeneous mixing models where any member of the population can infect or be infected by any other member of the population; see, for example, Anderson and May (1991) and Brauer (2008). The advantage of a homogeneous mixing model is that it lends itself relatively well to analysis and therefore is a good starting point. Due to the homogeneity assumption, these models predict that the fraction of the population that needs to be vaccinated to curtail an epidemic is equal to , where is the basic reproduction number (the average number of secondary infections caused by a typical infectious individual in a fully susceptible population). However, the homogeneous mixing assumption poorly reflects the actual interactions within a population, since, for example, school children and office co-workers spend significant amounts of time in close proximity and therefore are much more likely to infect each other than an elderly person who mostly stays at home. Consequently, efforts have been made to incorporate the network structure into models, where individuals are represented by nodes and contacts are presented by edges. In the context of the severe acute respiratory syndrome (SARS), it was shown by Meyers et al. (2005) that the incorporation of contact networks may yield different epidemic outcomes even for the same basic reproduction number . For pandemic influenza H1N1/09, Pourbohloul et al. (2009) and Davoudi et al. (2012) used network theory to obtain a real time estimate for . Numerical simulations have shown that different networks can yield distinct disease spread patterns; see, for example, Bansal et al. (2007), Miller et al. (2012), and Section 7.6 in Keeling and Rohani (2008). To illustrate this difference for the networks and parameters we use, the effect of different networks on disease dynamics is shown in Fig. 1
. Descriptions of these networks are given in Section 2 and Appendix B.
Fig. 1
Daily incidences (new infections) for the network topologies (see Section 2). On all networks, the average degree is 5, the population size is 200,000, the transmission rate is 0.06, the recovery rate is 0.2, and the initial number of infectious individuals is set to 100. Both graphs represent the same data but the left graph has a semi-log scale (highlighting the growth phase) while the right graph has a linear scale (highlighting the peak).
Daily incidences (new infections) for the network topologies (see Section 2). On all networks, the average degree is 5, the population size is 200,000, the transmission rate is 0.06, the recovery rate is 0.2, and the initial number of infectious individuals is set to 100. Both graphs represent the same data but the left graph has a semi-log scale (highlighting the growth phase) while the right graph has a linear scale (highlighting the peak).At the current stage, most theoretical network infectious disease models incorporate, from a real world perspective, idealized random network structures such as regular (all nodes have the same degree), Erdős–Rényi or scale-free random networks where clustering and spatial structures are absent. For example, Volz (2008) used a generating function formalism (an alternate derivation with a simpler system of equations was recently found by Miller, 2011), while we used the degree distribution in the effective degree model presented in Lindquist et al. (2011). In these models, the degree distribution is the key network characteristic for disease dynamics. From recent efforts (Ma et al., 2012, Volz et al., 2011, Moreno et al., 2003, Salathé and Jones, 2010) on incorporating degree correlation and clustering (such as households and offices) into epidemic models, it has been found that these may significantly affect the disease dynamics for networks with identical degree distributions. Fig. 2
shows disease dynamics on networks with identical degree distribution and disease parameters, but with different network topologies. Clearly, reliable predictions of the epidemic process that only use the degree distribution are not possible without knowledge of the network topology. Such predictions need to be checked by considering other topological properties of the network.
Fig. 2
Comparison of the incidence curves (as shown in (b)) on networks with identical disease parameters and degree distribution (as shown in (a)). The network topologies are the random, meta-random, and near neighbor networks. See Appendix B for details of the constructions of these networks.
Comparison of the incidence curves (as shown in (b)) on networks with identical disease parameters and degree distribution (as shown in (a)). The network topologies are the random, meta-random, and near neighbor networks. See Appendix B for details of the constructions of these networks.Network models allow more precise modeling of control measures that depend on the contact structure of the population, such as priority based vaccination and contact tracing. For example, Shaban et al. (2008) consider a random graph with a pre-specified degree distribution to investigate vaccination models using contact tracing. Kiss et al. (2006) compared the efficacy of contact tracing on random and scale-free networks and found that for transmission rates greater than a certain threshold, the final epidemic size is smaller on a scale-free network than on a corresponding random network, while they considered the effects of degree correlations in Kiss et al. (2008). Cohen et al. (2003) (see also Madar et al., 2004) considered different vaccination strategies on scale-free networks and found that acquaintance immunization is remarkably effective. Miller and Hyman (2007) considered several vaccination strategies on a simulation of the population of Portland Oregon, USA, and found it to be most effective to vaccinate nodes with the most unvaccinated susceptible contacts, although they found that this strategy may not be practical because it requires considerable computational resources and information about the network. Bansal et al. (2006) took a contact network using data from Vancouver, BC, Canada, considered two vaccination strategies, namely mortality- and morbidity-based, and investigated the detrimental effect of vaccination delays. Salathé and Jones (2010) and Salathé et al. (2010) found that, on realistic contact networks, vaccination strategies based on detailed network topology information generally outperform random vaccination.However, in most cases, contact network topologies are not readily available. Thus, how different network topologies affect various vaccination strategies remains of considerable interest. To address this question, we explore two scenarios to compare percentage reduction by vaccination on the final size of epidemics across various network topologies. First, various network topologies are considered with the disease parameters constant, assuming that these have been independently estimated. Second, different network topologies are used to fit to the observed incidence curve (number of new infections in each day), so that their disease parameters are different yet they all line up to the same initial exponential growth phase of the epidemic.Vaccines are likely lacking at the outbreak of an emerging infectious disease (as seen in the 2009 H1N1 pandemic, Conway et al., 2011), and thus can only be given after the disease is already widespread. We investigate numerically whether network topologies affect the effectiveness of vaccination strategies started with a delay after the disease is widespread; for example, a 40 day delay as in the second wave of the 2009 influenza pandemic in British Columbia, Canada (Office of the Provincial Health Officer, 2010). Details of our numerical simulations are given in Appendix A.This paper is structured as follows. In Section 2, a brief overview of the networks and vaccination strategies (more details are provided in Appendix B, Appendix C) is given. In Section 3, we investigate the scenario where the transmission rate is fixed, while in Section 4 we investigate the scenario where the growth rate of the incidence curve is fixed. To this end, we compute the incidence curves and reductions in final sizes (total number of infections during the course of the epidemic) due to vaccination. For the homogeneous mixing model, these scenarios are identical (Ma and Earn, 2006), but as will be shown, when taking topology into account, they are completely different. We end with conclusions in Section 5.
Networks, vaccination trategies, and parameters
Contact networks
Detailed network topologies for human populations are far from known. However, this detailed knowledge may not be required when the main objective is to assert the impact that topology has on the spread of a disease and on the effects of vaccination. It may be sufficient to consider a number of representative network topologies that, at least to some extent, can be found in the actual population. Here, we consider the four topologies listed in Table 1
, which we now briefly describe.
Table 1
Illustration of the different types of networks used in this paper.
Random
Scale-free
Small world
Meta-random
Illustration of the different types of networks used in this paper.In the random network, nodes are connected with equal probability yielding a Poisson degree distribution. In a scale-free network, small number of nodes have a very large number of links and large number of nodes have a small number of links such that the degree distribution follows a power law. Small world (SW) networks are constructed by adding links between randomly chosen nodes on networks in which nodes are connected to the nearest neighbors. The last network considered is what we term a meta-random network where random networks of various sizes are connected with a small number of interlinks. All networks are undirected with no self loops or multiple links. The histograms of the networks are shown in Table 2
, and the details of their construction are given in Appendix B.
Table 2
Degree histograms of the networks in Table 1 with 200,000 nodes.
Random
Scale-free
Small world
Meta-random
Degree histograms of the networks in Table 1 with 200,000 nodes.
Vaccination strategies
The vaccination strategies considered are summarized in Table 3
. In the random strategy, an eligible node is randomly chosen and vaccinated. In the prioritized strategy, nodes with the highest degrees are vaccinated first, while in the follow links strategy, inspired by notions from social networks, a randomly chosen susceptible node is vaccinated and then all its neighbors and then its neighbor's neighbors and so on. Finally, in contact tracing, the neighbors of infectious nodes are vaccinated.
Table 3
Illustration of vaccination strategies. Susceptible nodes are depicted by triangles, infectious nodes by squares, and the vaccinated nodes by circles. The average degree in these illustrations has been reduced to aid clarity. The starting point for contact tracing is labeled as A while the starting point for the follow links strategy is labeled as B. The number of doses dispensed in this illustration is 3.
Prioritized
Random
Follow links
Contact tracing
Illustration of vaccination strategies. Susceptible nodes are depicted by triangles, infectious nodes by squares, and the vaccinated nodes by circles. The average degree in these illustrations has been reduced to aid clarity. The starting point for contact tracing is labeled as A while the starting point for the follow links strategy is labeled as B. The number of doses dispensed in this illustration is 3.For all the strategies, vaccination is voluntary and quantity limited. That is, only susceptibles who do not refuse vaccination are vaccinated and each day only a certain number of doses is available. In the case of (relatively) new viral diseases, the supply of vaccines will almost certainly be constrained, as was the case for the pandemic influenza H1N1/09 virus. Also in the case of mass vaccinations, there will be resource limitations with regard to how many doses can be administered per day.The report (Office of the Provincial Health Officer, 2010) states that the vaccination program was prioritized and it took 3 weeks before the general population had access to vaccination. Thus we assume that a vaccination program can be completed in 4–6 weeks or about 40 days, this means that for a population of 200,000, a maximum of 5000 doses a day can be used. For each strategy for each time unit, first a group of eligible nodes is identified and then up to the maximum number of doses is dispensed among the eligible nodes according to the strategy chosen. More details of the vaccination strategies and their motivations are given in Appendix C.To study the effect of delayed availability of vaccines during an emerging infectious disease, we compare the effect of vaccination programs starting on the first day of the epidemic with those vaccination programs starting on different days. These range from 5 to 150 days after the start of the epidemic, with an emphasis on a 40 day delay that occurred in British Columbia, Canada, during the influenza H1N1/2009 pandemic.When a node is vaccinated, the vaccination is considered to be ineffective in 30% of the cases (Bansal et al., 2006). In such cases, the vaccine provides no immunity at all. For the 70% of the nodes for which the vaccine will be effective, a two week span to reach full immunity is assumed (Clark et al., 2009). During the two weeks, we assume that the immunity increases linearly starting with 0 at the time of vaccination reaching 100% after 14 days.
Parameters
The effect of vaccination strategies has been studied (see, for example, Conway et al., 2011) using disease parameter values estimated in the literature. However, network topologies were not the focus of these studies. In Section 3, the effect of vaccination strategies on various network topologies is compared with a fixed per link transmission rate. The per link transmission rate is difficult to obtain directly and is usually derived as a secondary quantity. To determine , we pick the basic reproduction number and the recovery rate , which are close to that of the influenza A H1N1/09 virus; see, for example, Pourbohloul et al. (2009), Tuite et al. (2010). In the case of the homogeneous mixing SIR model, the basic reproduction number is given by , where is the per-node transmission rate. Our parameter values yield . For networks, . With the assumption that the average degree , the above gives the per-link transmission rate . The key parameters are summarized in Table 4
. In Section 3, we use this transmission rate to compare the incidence curves for the networks in Table 1 with the vaccination strategies in Table 3.
Table 4
Values of the key parameters and settings.
Parameter
Value(s)
Used in
Population size N
200,000
All
Maximum degree M
100
All
Average degree 〈k〉
5
All
Recovery rate γ
0.2/day
All
Vaccination refusal
50%
All
Vaccine effectiveness
70%
All
Doses per day
5000
All
Time to immunity
14 days
All
Shortcut ratio
0.05
Small world
External link probability
0.01
Meta-random
Values of the key parameters and settings.Some of the most readily available data in an epidemic are the number of reported new cases per day. These cases generally display exponential growth in the initial phase of an epidemic and a suitable model therefore needs to match this initial growth pattern. The exponential growth rates are commonly used to estimate disease parameters (Chowell et al., 2007, Lipsitch et al., 2003). In Section 4, we consider the effects of various network topologies on the effectiveness of vaccination strategies for epidemics with a fixed exponential growth rate. The basic reproduction number and the recovery rate yield an exponential growth rate for the homogeneous mixing SIR model. We tune the transmission rate for each network topology to give this initial growth rate.
Results for a given transmission rate
In this section, the effectiveness of vaccination strategies on various network topologies is investigated for a given set of parameters, which are identical for all the simulations. The values of the disease parameters are chosen based on what is known from influenza H1N1/09. Qualitatively, these chosen parameters should provide substantial insight into the effects topology has on the spread of a disease. Unless indicated otherwise the parameter values listed in Table 4 are used.The effects of the vaccination strategies summarized in Table 3 when applied without delay are shown in Fig. 3
. For reference, Fig. 1 shows the incidence curves with no vaccination. Since the disease dies out in the small world network (see Fig. 1), vaccination is not needed in this network for the parameter values taken. Especially in the cases of the random and meta-random networks, the effects of vaccination are drastic while for the scale-free network they are still considerable. What is particularly notable is that when comparing the various outcomes, topology has as great if not a greater impact on the epidemic than the vaccination strategy.
Fig. 3
The effects of the vaccination strategies summarized in Table 3 for the network topologies in Table 1 given a fixed transmission rate . There is no delay in the vaccination and parameters are equal to those used in Fig. 1.
The effects of the vaccination strategies summarized in Table 3 for the network topologies in Table 1 given a fixed transmission rate . There is no delay in the vaccination and parameters are equal to those used in Fig. 1.Besides the incidence curves, the final sizes of epidemics and the effect vaccination has on these are also of great importance. Table 5
shows the final sizes and the reductions in the final sizes for the various networks on which the disease can survive (for the chosen parameter values) with vaccination strategies for the cases where there is no delay in the vaccination. Fig. 4
and Table 6
show the incidence curves and the reductions in final sizes for the same parameters as used in Fig. 3 and Table 5 but with a delay of 40 days in the vaccination.
Table 5
Reduction in the final sizes for given without delay. This table is based on the same data as in Fig. 3.
Network strategy
Random
Scale-free
Meta-random
None
38,602 (0%)
73,794 (0%)
10,488 (0%)
Prioritized
941 (98%)
16,743 (77%)
909 (91%)
Random
1115 (97%)
23,129 (69%)
1078 (90%)
Follow links
1106 (97%)
22,561 (69%)
1077 (90%)
Contact tracing
1058 (97%)
21,704 (71%)
993 (91%)
Fig. 4
The results for Fig. 3 if the vaccination start is delayed by 40 days.
Table 6
Reduction in the final sizes for given with a delay of 40 days. This table is based on the same data as in Fig. 4.
Network strategy
Random
Scale-free
Meta-random
None
38,602 (0%)
73,794 (0%)
10,488 (0%)
Prioritized
4534 (88%)
69,990 (5%)
3567 (66%)
Random
5106 (87%)
70,956 (4%)
3854 (63%)
Follow links
4695 (88%)
71,641 (3%)
3829 (63%)
Contact tracing
4426 (89%)
70,381 (5%)
3774 (64%)
Reduction in the final sizes for given without delay. This table is based on the same data as in Fig. 3.The results for Fig. 3 if the vaccination start is delayed by 40 days.Reduction in the final sizes for given with a delay of 40 days. This table is based on the same data as in Fig. 4.As can be expected for the given parameters, a delay has the biggest effect for the scale-free network. In that case, the epidemic is already past its peak and vaccinations only have a minor effect. For the random and meta-random networks, the effects of the delay are significant, increasing the final size by a factor of about 4. Nevertheless, the various vaccination strategies have sufficient time to curtail the spread of the disease.To further investigate the effects of delay in the case of random vaccination, we compute reductions in final sizes for delays of 5, 10, 15,…,150 days, in random, scale-free, and meta-random networks. Fig. 5
shows that, not surprisingly, these reductions diminish with longer delays. However, the reductions are strongly network dependent. On a scale-free network, the reduction becomes negligible as the delay approaches the epidemic peak time, while on random and meta-random networks, the reduction is about 40% with the delay at the epidemic peak time.
Fig. 5
Upper: the incidence curves with no vaccination on various networks, showing the epidemic peak time for comparison with the delay time. Lower: the final size reduction as a function of delay in random vaccination on various networks.
Upper: the incidence curves with no vaccination on various networks, showing the epidemic peak time for comparison with the delay time. Lower: the final size reduction as a function of delay in random vaccination on various networks.This section clearly shows that given a certain transmission rate , the effectiveness of a vaccination strategy is impossible to predict without having reliable data on the network topology of the population. Next, we consider the case where instead of the transmission rate, the initial growth rate is given.
Results for a given exponential growth rate
We line up incidence curves on various network topologies to a growth rate predicted by a homogeneous mixing SIR model with the basic reproduction number and recovery rate (in this case with exponential, ). Table 7
summarizes the transmission rates that yield this exponential growth rate on the corresponding network topologies. The initial number of infectious individuals for models on each network topology needs to be adjusted as well so that the curves line up along the homogeneous mixing SIR incidence curve for 25 days. As can be seen from the table, the variations in the parameters are indeed very large, with the transmission rate for the small world network being nearly 8 times the value of the transmission rate for the scale-free network.
Table 7
Transmission rates and initial number of infections for the studied network topologies necessary to match the given exponential growth curve for days. The homogeneous network gives the exponential reference growth.
Network
β
Initial infections
Incidences on day 1
Homogeneous
0.06
40
44
Random
0.0808
100
43
Scale-free
0.0457
160
40
Small world
0.35
18
41
Meta-random
0.082
100
43
Transmission rates and initial number of infections for the studied network topologies necessary to match the given exponential growth curve for days. The homogeneous network gives the exponential reference growth.
Disease epidemics with no vaccination
The incidence curves corresponding to the parameters in Table 7 are shown in Fig. 6
. As can clearly be seen, for these parameters, the curves overlap very well for the first 25 days, thus showing indeed the desired identical initial growth rates. However, it is also clear that the curves diverge strongly later on, with the epidemic on the small world network being the most severe. These results show that the spread of an epidemic cannot be predicted on the basis of having a good estimate of the growth rate alone. In addition, comparing Fig. 1, Fig. 6, a higher transmission rate yields a much larger final size and a longer epidemic on the meta-random network.
Fig. 6
Daily incidences for the network topologies in Table 1 without vaccination for the case where the initial growth rate is given. The transmission rates and initial number of infections for the various network topologies are given in Table 7, while the remaining parameters are the same as in Fig. 1. All the three sub-figures are based on the same data but show different representations for clarity, where the left-hand figures are in the log-linear scale (to emphasize the exponential growth) and the right-hand figure is in the linear scale (to emphasize the peak).
Daily incidences for the network topologies in Table 1 without vaccination for the case where the initial growth rate is given. The transmission rates and initial number of infections for the various network topologies are given in Table 7, while the remaining parameters are the same as in Fig. 1. All the three sub-figures are based on the same data but show different representations for clarity, where the left-hand figures are in the log-linear scale (to emphasize the exponential growth) and the right-hand figure is in the linear scale (to emphasize the peak).
The effectiveness of vaccination strategies
The effects of the various vaccination strategies for the case of a given growth rate are shown in Fig. 7
. Given the large differences in the transmission rates, it may be expected that the final sizes show significant differences as well. This is indeed the case as can be seen in Table 8
, which shows the percentage reduction in final sizes for the various vaccination strategies. With no vaccination, the final size of the small world network is more than 3 times that of the scale-free network, but for all except the follow links vaccination strategy the percentage reduction on the small world network is greater.
Fig. 7
The effects of the vaccination strategies for different topologies when the initial growth rate is given. The transmission rates are as indicated in Table 7, while the remaining parameters are identical to those in Fig. 6.
Table 8
Reduction in the final sizes due to vaccination for the case where the growth rate is given. This table is based on the same data as in Fig. 7.
Network strategy
Random
Scale-free
Small world
Meta-random
None
105,386 (0%)
46,655 (0%)
150,535 (0%)
98,608 (0%)
Prioritized
4224 (96%)
4597 (90%)
2229 (98%)
4141 (95%)
Random
7530 (93%)
6640 (86%)
3054 (98%)
5769 (94%)
Follow links
5921 (94%)
6679 (86%)
28,315 (81%)
5787 (94%)
Contact tracing
5929 (94%)
6500 (86%)
2710 (98%)
4770 (95%)
The effects of the vaccination strategies for different topologies when the initial growth rate is given. The transmission rates are as indicated in Table 7, while the remaining parameters are identical to those in Fig. 6.Reduction in the final sizes due to vaccination for the case where the growth rate is given. This table is based on the same data as in Fig. 7.The effects of a 40-day delay in the start of the vaccination are shown in Fig. 8
and Table 9
. Besides the delay, all the parameters are identical to those in Fig. 7 and Table 8. The delay has the largest effect on the final sizes of the small world network, increasing it by a factor of 20–30 except in the follow links case. On a scale-free network, the delay renders all vaccination strategies nearly ineffective.
Fig. 8
As for Fig. 7 if the vaccination start is delayed by 40 days.
Table 9
Reduction in the final sizes when there is a delay of 40 days in the start of the vaccination program. This table is based on the same data as in Fig. 8.
Network strategy
Random
Scale-free
Small world
Meta-random
None
105,074 (0%)
46,056 (0%)
152,536 (0%)
99,950 (0%)
Prioritized
64,937 (38%)
33,660 (27%)
68,319 (55%)
37,494 (62%)
Random
69,552 (34%)
36,105 (22%)
71,947 (53%)
39,692 (60%)
Follow links
68,874 (34%)
36,219 (21%)
98,370 (36%)
39,877 (60%)
Contact tracing
69,936 (33%)
34,488 (25%)
73,780 (52%)
39,523 (60%)
As for Fig. 7 if the vaccination start is delayed by 40 days.Reduction in the final sizes when there is a delay of 40 days in the start of the vaccination program. This table is based on the same data as in Fig. 8.These results also confirm the importance of network topology in disease spread even when the incidence curves have identical initial growth. The initial stages of an epidemic are insufficient to estimate the effectiveness of a vaccination strategy on reducing the peak or final size of an epidemic.
Conclusions
The relative importance of network topology on the predictability of incidence curves was investigated. This was done by considering whether the effectiveness of several vaccination strategies is impacted by topology, and whether the growth in the daily incidences has a network topology independent relation with the disease transmission rate. It was found that without a fairly detailed knowledge of the network topology, initial data cannot predict epidemic progression. This is so for both a given transmission rate and a given growth rate .For a fixed transmission rate and thus a fixed per link transmission probability, given that a disease spreads on a network with a fixed average degree, the disease spreads fastest on scale-free networks because high degree nodes have a very high probability to be infected as soon as the epidemic progresses. In turn, once a high degree node is infected, on average it passes on the infection to a large number of neighbors. The random and meta-random networks show identical initial growth rates because they have the same local network topology. On different network topologies, diseases respond differently to parameter changes. For example, on the random network, a higher transmission rate yields a much shorter epidemic, whereas on the meta-random network, it yields a longer one with a more drastic increase in final size. These differences are caused by the spatial structures in the meta-random network. Considering that a meta-random network is a random network of random networks, it is likely that the meta-random network represents a general population better than a random network.For a fixed exponential growth rate, the transmission rate needed on the scale-free network to yield the given initial growth rate is the smallest, being about half that of the random and the meta-random networks. Hence, the per-link transmission probability is the lowest on the scale-free network, which in turn yields a small epidemic final size.For different network topologies, we quantified the effect of delay in the start of vaccination. We found that the effectiveness of vaccination strategies decreases with delay with a rate strongly dependent on network topology. This emphasizes the importance of the knowledge of the topology, in order to formulate a practical vaccination schedule.With respect to policy, the results presented seem to warrant a significant effort to obtain a better understanding of how the members of a population are actually linked together in a social network. Consequently, policy advice based on the rough estimates of the network structure should be viewed with caution.
Authors: Marc Lipsitch; Ted Cohen; Ben Cooper; James M Robins; Stefan Ma; Lyn James; Gowri Gopalakrishna; Suok Kai Chew; Chorh Chuan Tan; Matthew H Samore; David Fisman; Megan Murray Journal: Science Date: 2003-05-23 Impact factor: 47.728
Authors: Ashleigh R Tuite; Amy L Greer; Michael Whelan; Anne-Luise Winter; Brenda Lee; Ping Yan; Jianhong Wu; Seyed Moghadas; David Buckeridge; Babak Pourbohloul; David N Fisman Journal: CMAJ Date: 2009-12-03 Impact factor: 8.262
Authors: Tristan W Clark; Manish Pareek; Katja Hoschler; Helen Dillon; Karl G Nicholson; Nicola Groth; Iain Stephenson Journal: N Engl J Med Date: 2009-09-10 Impact factor: 91.245
Authors: Babak Pourbohloul; Armando Ahued; Bahman Davoudi; Rafael Meza; Lauren A Meyers; Danuta M Skowronski; Ignacio Villaseñor; Fernando Galván; Patricia Cravioto; David J D Earn; Jonathan Dushoff; David Fisman; W John Edmunds; Nathaniel Hupert; Samuel V Scarpino; Jesús Trujillo; Miguel Lutzow; Jorge Morales; Ada Contreras; Carolina Chávez; David M Patrick; Robert C Brunham Journal: Influenza Other Respir Viruses Date: 2009-09 Impact factor: 4.380
Authors: Sara Schärrer; Stefan Widgren; Heinzpeter Schwermer; Ann Lindberg; Beatriz Vidondo; Jakob Zinsstag; Martin Reist Journal: BMC Vet Res Date: 2015-07-14 Impact factor: 2.741
Authors: Samuel F Rosenblatt; Jeffrey A Smith; G Robin Gauthier; Laurent Hébert-Dufresne Journal: PLoS Comput Biol Date: 2020-07-09 Impact factor: 4.475
Authors: T Alex Perkins; Robert C Reiner; Guido España; Quirine A Ten Bosch; Amit Verma; Kelly A Liebman; Valerie A Paz-Soldan; John P Elder; Amy C Morrison; Steven T Stoddard; Uriel Kitron; Gonzalo M Vazquez-Prokopec; Thomas W Scott; David L Smith Journal: PLoS Comput Biol Date: 2019-03-20 Impact factor: 4.475
Authors: Nicholas Bbosa; Deogratius Ssemwanga; Rebecca N Nsubuga; Noah Kiwanuka; Bernard S Bagaya; John M Kitayimbwa; Alfred Ssekagiri; Gonzalo Yebra; Pontiano Kaleebu; Andrew Leigh-Brown Journal: Viruses Date: 2021-05-24 Impact factor: 5.048